Matches in Wikidata for { <http://www.wikidata.org/entity/Q86284882> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q86284882 description "clinical trial" @default.
- Q86284882 description "ensayu clínicu" @default.
- Q86284882 description "klinisch onderzoek" @default.
- Q86284882 description "клінічне випробування" @default.
- Q86284882 name "Study of CPI-444 as a Single Agent and in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma" @default.
- Q86284882 name "Study of CPI-444 as a Single Agent and in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma" @default.
- Q86284882 type Item @default.
- Q86284882 label "Study of CPI-444 as a Single Agent and in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma" @default.
- Q86284882 label "Study of CPI-444 as a Single Agent and in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma" @default.
- Q86284882 prefLabel "Study of CPI-444 as a Single Agent and in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma" @default.
- Q86284882 prefLabel "Study of CPI-444 as a Single Agent and in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma" @default.
- Q86284882 P1050 Q86284882-6CBDFAB4-4BFB-4B83-8A5C-BC6F2E90BD93 @default.
- Q86284882 P1132 Q86284882-2E6B79A1-46EA-4CEF-9305-888B9DEF6783 @default.
- Q86284882 P1476 Q86284882-C2468557-91E1-459B-A944-3081FE18647F @default.
- Q86284882 P17 Q86284882-F6168257-63CE-4E4A-98F2-4E920A7E8289 @default.
- Q86284882 P2899 Q86284882-E11F9B10-A0D7-4527-849A-8960F1796E39 @default.
- Q86284882 P3098 Q86284882-1A00F038-9DE9-4EAE-8475-B0254CB2F215 @default.
- Q86284882 P31 Q86284882-57835C68-D56C-451A-8811-B6A0646D72BE @default.
- Q86284882 P4135 Q86284882-6C8EE42C-2A1A-4C85-A917-8E29F2E8CB7E @default.
- Q86284882 P4844 Q86284882-AEEE7632-BA49-4A1D-87B8-48E1E727B098 @default.
- Q86284882 P580 Q86284882-E99F635F-9FB4-4AC6-85B1-E61F136C3D9B @default.
- Q86284882 P582 Q86284882-7AB199B2-B2B0-451E-A130-3B9129E54424 @default.
- Q86284882 P6099 Q86284882-5190956C-B0DB-408F-83AD-D26DAD87B8F0 @default.
- Q86284882 P8363 Q86284882-9F9893DE-1674-4D83-B778-092CAF2B3981 @default.
- Q86284882 P1050 Q467635 @default.
- Q86284882 P1132 "+28" @default.
- Q86284882 P1476 "A Phase 1b, Open-Label Study of CPI-444 as a Single Agent and in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma" @default.
- Q86284882 P17 Q30 @default.
- Q86284882 P2899 "+18" @default.
- Q86284882 P3098 "NCT04280328" @default.
- Q86284882 P31 Q30612 @default.
- Q86284882 P4135 "+80" @default.
- Q86284882 P4844 Q5222113 @default.
- Q86284882 P580 "2020-02-28T00:00:00Z" @default.
- Q86284882 P582 "2023-02-07T00:00:00Z" @default.
- Q86284882 P6099 Q5452194 @default.
- Q86284882 P8363 Q78089383 @default.